PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

PerkinElmer (NYSE: PKI) announced its participation in the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum scheduled for March 21, 2023, at 2:15 p.m. ET.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 at 2:15 p.m. ET.

Steve Willoughby, senior vice president, investor relations & head of ESG, and Alan Fletcher, senior vice president, Life Sciences, will provide an update on the Company and its strategic priorities. To register, click here.

A live audio webcast will be available on the Events section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer Investor Relations website after the event and will be available for at least 30 days.

About PerkinElmer
PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $4.6 billion in 2022, has more than 16,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available at www.perkinelmer.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230309005013/en/

Investor Relations:
Steve Willoughby
(781) 663-5677
steve.willoughby@perkinelmer.com

Media Relations:
Chet Murray
(781) 663-5719
chet.murray@perkinelmer.com

Source: PerkinElmer Inc.